ArticleAdvances in hematology2024

Early Molecular Response to Imatinib First-Line Therapy and Predictive Factors of Poor Outcomes for Chronic Myeloid Leukemia Patients in Côte d'Ivoire.

Kouassi Gustave Koffi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.